Hideo Harigae Selected Research

Autoantigens

1/2020	Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis.
10/2013	A novel autoantibody against ephrin type B receptor 2 in acute necrotizing encephalopathy.
1/2013	An innovative method to identify autoantigens expressed on the endothelial cell surface: serological identification system for autoantigens using a retroviral vector and flow cytometry (SARF).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideo Harigae Research Topics

Disease

21	Neoplasms (Cancer) 09/2022 - 12/2004
15	Lymphoma (Lymphomas) 01/2022 - 03/2002
14	Sideroblastic Anemia 01/2022 - 06/2003
13	Infections 08/2021 - 04/2004
11	X-linked sideroblastic anemia 01/2022 - 06/2003
11	Leukemia 01/2019 - 06/2004
9	Multiple Myeloma 01/2024 - 01/2009
9	Anemia 01/2018 - 06/2003
8	Inflammation (Inflammations) 01/2024 - 02/2016
8	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2023 - 01/2011
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 12/2005
8	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 08/2005
7	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2007
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2021 - 06/2002
6	Rheumatoid Arthritis 06/2022 - 06/2010
6	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2011
5	T-Cell Lymphoma (Lymphoma, T Cell) 04/2022 - 10/2006
5	Autoimmune Diseases (Autoimmune Disease) 05/2021 - 01/2013
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 04/2010
4	COVID-19 01/2024 - 01/2022
4	Pain (Aches) 12/2023 - 02/2009
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2023 - 10/2009
4	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2023 - 01/2015
4	Takayasu Arteritis (Arteritis, Takayasu's) 06/2022 - 11/2019
4	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 04/2022 - 01/2009
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 09/2004
4	Disease Progression 11/2018 - 01/2009
4	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 03/2017 - 11/2011
4	Hematologic Diseases (Blood Diseases) 03/2014 - 10/2003
3	Pneumonia (Pneumonitis) 01/2024 - 04/2004
3	Fibrosis (Cirrhosis) 01/2024 - 01/2016
3	Aplastic Anemia (Anemia, Hypoplastic) 08/2023 - 05/2010
3	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 11/2022 - 01/2018
3	Pathologic Complete Response 09/2022 - 07/2009
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2016
3	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022 - 01/2009
3	Acute Promyelocytic Leukemia 01/2022 - 07/2008
3	Exanthema (Rash) 01/2022 - 09/2004
3	Fever (Fevers) 01/2022 - 02/2009
3	Vasculitis (Vasculitides) 05/2021 - 07/2012
3	Systemic Scleroderma (Systemic Sclerosis) 01/2020 - 01/2016
3	Thrombotic Thrombocytopenic Purpura 01/2017 - 01/2009
3	Hepatitis B 01/2015 - 11/2013
3	Hemolytic Anemia 01/2013 - 01/2010
3	Collagen Diseases (Collagen Disease) 01/2013 - 01/2009
3	Philadelphia Chromosome 07/2011 - 09/2004
2	Thrombosis (Thrombus) 01/2024 - 08/2016
2	Hemolysis 12/2023 - 01/2010
2	Pancytopenia 08/2023 - 06/2003
2	Vasovagal Syncope 03/2023 - 01/2022
2	Hypersensitivity (Allergy) 03/2023 - 02/2009
2	Syncope (Fainting) 03/2023 - 01/2022
2	Iron Deficiencies 01/2023 - 01/2017
2	Large Granular Lymphocytic Leukemia 01/2023 - 01/2010
2	Eosinophilia 11/2022 - 01/2009
2	Cerebral Hemorrhage 11/2022 - 09/2020
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 09/2022 - 10/2006

Drug/Important Bio-Agent (IBA)

13	Heme (Haem)IBA 01/2023 - 02/2002
11	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2003
11	IronIBA 01/2023 - 10/2008
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 04/2004
10	Rituximab (Mabthera)FDA Link 11/2022 - 07/2009
10	Prednisolone (Predate)FDA LinkGeneric 10/2022 - 07/2009
10	EnzymesIBA 11/2019 - 01/2010
9	AntibodiesIBA 10/2023 - 06/2003
9	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2022 - 01/2009
9	AutoantibodiesIBA 01/2022 - 07/2009
7	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2003
6	Transcription Factors (Transcription Factor)IBA 10/2018 - 06/2004
6	CytokinesIBA 02/2016 - 11/2006
5	SteroidsIBA 08/2023 - 06/2003
5	Methotrexate (Mexate)FDA LinkGeneric 09/2022 - 04/2007
5	5-Aminolevulinate SynthetaseIBA 01/2022 - 06/2003
5	Tacrolimus (Prograf)FDA LinkGeneric 10/2020 - 04/2007
5	SulfurIBA 01/2019 - 10/2010
5	Imatinib Mesylate (Gleevec)FDA Link 12/2015 - 09/2004
4	tisagenlecleucelIBA 01/2024 - 01/2022
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 11/2022 - 01/2018
4	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021 - 11/2013
4	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020 - 12/2005
4	Immunoglobulin G (IgG)IBA 11/2018 - 07/2012
4	Messenger RNA (mRNA)IBA 02/2014 - 06/2002
3	Plasminogen Activators (Plasminogen Activator)IBA 01/2024 - 06/2022
3	VaccinesIBA 12/2023 - 01/2022
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2012
3	tocilizumab (atlizumab)FDA Link 06/2022 - 06/2010
3	CreatinineIBA 01/2021 - 01/2010
3	AutoantigensIBA 01/2020 - 01/2013
3	Bortezomib (Velcade)FDA Link 11/2018 - 04/2009
2	Plasminogen Activator Inhibitor 1IBA 01/2024 - 01/2023
2	Brentuximab VedotinIBA 09/2022 - 05/2020
2	Interleukin-6 (Interleukin 6)IBA 06/2022 - 01/2015

Therapy/Procedure

37	Therapeutics 11/2022 - 06/2003
24	Drug Therapy (Chemotherapy) 01/2024 - 12/2004
14	Hematopoietic Stem Cell Transplantation 09/2022 - 09/2004
13	Transplantation 10/2023 - 04/2004
7	Stem Cell Transplantation 06/2022 - 04/2004
3	Aftercare (After-Treatment) 06/2013 - 04/2010
2	Plasmapheresis 08/2023 - 01/2009
2	Induction Chemotherapy 09/2022 - 01/2022